Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constance Delaby

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Neurology|April 14, 2026
Influence of Decreased Kidney Function on Plasma Biomarkers of Neurodegenerative Disorders in Routine Care: Confirmation of the Interest of RatiosEtienne Mondésert, Jean-Paul Cristol, Anne-Sophie Bargnoux, et al.
Blood|June 10, 2011
ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyriaJordi To-Figueras, Sarah Ducamp, Jerome Clayton, et al.
Frontiers in Aging Neuroscience|November 17, 2022
Neurofilaments contribution in clinic: state of the artConstance Delaby, Olivier Bousiges, Damien Bouvier, et al.
Alzheimer'S Research & Therapy|June 3, 2015
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric studyJulien Dumurgier, Susanna Schraen, Audrey Gabelle, et al.
Annales De Biologie Clinique|December 1, 2022
Neurofilaments: a key new biomarker for clinicians. Part 1: Importance of neurofilaments in the management of neurodegenerative diseasesConstance Delaby, Olivier Bousiges, Damien Bouvier, et al.
Annales De Biologie Clinique|December 1, 2022
Neurofilaments: a key new biomarker for clinicians. Part 2: Neurofilaments, an asset beyond neurodegenerative diseasesConstance Delaby, Olivier Bousiges, Damien Bouvier, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|October 15, 2013
Epistasis in iron metabolism: complex interactions between Cp, Mon1a, and Slc40a1 loci and tissue iron in miceConstance Delaby, Vincent Oustric, Caroline Schmitt, et al.
Haematologica|February 2, 2017
Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease modelSarah Millot, Constance Delaby, Boualem Moulouel, et al.
Alzheimer'S Research & Therapy|February 13, 2025
Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementiaConstance Delaby, Daniel Alcolea, Germain Busto, et al.
Alzheimer'S Research & Therapy|October 3, 2020
Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individualsSylvain Lehmann, Julien Dumurgier, Xavier Ayrignac, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Neurology|April 14, 2026
Influence of Decreased Kidney Function on Plasma Biomarkers of Neurodegenerative Disorders in Routine Care: Confirmation of the Interest of RatiosEtienne Mondésert, Jean-Paul Cristol, Anne-Sophie Bargnoux, et al.
Blood|June 10, 2011
ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyriaJordi To-Figueras, Sarah Ducamp, Jerome Clayton, et al.
Frontiers in Aging Neuroscience|November 17, 2022
Neurofilaments contribution in clinic: state of the artConstance Delaby, Olivier Bousiges, Damien Bouvier, et al.
Alzheimer'S Research & Therapy|June 3, 2015
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric studyJulien Dumurgier, Susanna Schraen, Audrey Gabelle, et al.
Annales De Biologie Clinique|December 1, 2022
Neurofilaments: a key new biomarker for clinicians. Part 1: Importance of neurofilaments in the management of neurodegenerative diseasesConstance Delaby, Olivier Bousiges, Damien Bouvier, et al.
Annales De Biologie Clinique|December 1, 2022
Neurofilaments: a key new biomarker for clinicians. Part 2: Neurofilaments, an asset beyond neurodegenerative diseasesConstance Delaby, Olivier Bousiges, Damien Bouvier, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|October 15, 2013
Epistasis in iron metabolism: complex interactions between Cp, Mon1a, and Slc40a1 loci and tissue iron in miceConstance Delaby, Vincent Oustric, Caroline Schmitt, et al.
Haematologica|February 2, 2017
Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease modelSarah Millot, Constance Delaby, Boualem Moulouel, et al.
Alzheimer'S Research & Therapy|February 13, 2025
Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementiaConstance Delaby, Daniel Alcolea, Germain Busto, et al.
Alzheimer'S Research & Therapy|October 3, 2020
Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individualsSylvain Lehmann, Julien Dumurgier, Xavier Ayrignac, et al.
Pageof 8